Estradiol regulation of α(1b)-adrenoceptor mRNA in female rat hypothalamus-preoptic area

Journal of Neuroendocrinology

Volumn 8, Issue 6, 1996, Pages 449-455

  Karkanias, G B ^a   Ansonoff, M A ^a   Etgen, A M ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

Cortex; Estrogen; Hypothalamus; mRNA levels; (1b) adrenoceptor

Indexed keywords

ALPHA 1B ADRENERGIC RECEPTOR; COMPLEMENTARY DNA; ESTRADIOL; ESTRADIOL BENZOATE; ESTROGEN RECEPTOR; MESSENGER RNA;

ANIMAL CELL; ARTICLE; BRAIN REGION; CEREBELLUM; CONTROLLED STUDY; ESTROGEN THERAPY; FEMALE; GENE AMPLIFICATION; GENE EXPRESSION REGULATION; HYPOTHALAMUS; NONHUMAN; NORTHERN BLOTTING; OVARIECTOMY; PREOPTIC AREA; PRIORITY JOURNAL; RAT; RECEPTOR DENSITY; REPRODUCTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 0029767697     PISSN: 09538194     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2826.1996.04716.x     Document Type: Article

References (44)

1. Pfaff DW. In: Estrogens and brain function. New York: Springer-Verlag, 1980.
2. Etgen AM, Ungar S, Petitti N. Estradiol and progesterone modulation of norepinephrine neurotransmission: Implications for the regulation of female reproductive behavior. J Neuroendocrinol 1992; 4: 255-271.
3. 2 and luteinizing hormone-releasing hormone release from the median eminence. Endocrinology 1982; 110: 409-412.
4. Coen CW, Coombs MC. Effects of manipulating catecholamines on the incidence of the preovulatory surge of luteinizing hormone and ovulation in the rat: evidence for a necessary involvement of hypothalamic adrenaline in the normal or 'midnight' surge. Neuroscience 1983; 10: 187-206.
5. Taleisnik S, Sawyer CH. Activation of the CNS noradrenergic system may inhibit as well as facilitate luteinizing hormone release. Neuroendocrinology 1986; 44: 265-268.
6. 1-adrenergic agonists act on the ventromedial hypothalamus to cause neuronal excitation and lordosis facilitation: electrophysiological and behavioral evidence. Brain Res 1992; 588: 237-245.
7. Perkins JP, Moore MM. Characterization of the adrenergic receptors mediating a rise in cyclic 3′,5′-adenosine monophosphate in rat cerebral cortex. J Pharmacol Exp Ther 1973; 185: 371-378.
8. Daly JW, Padgett W, Nimitkitpaisan Y, Creveling CR, Cantacuzene D, Kirk KL. Fluoronorepinephrine: Specific agonists for the activation of α and β adrenergic sensitive cyclic AMP-generating systems in brain slices. J Pharmacol Exp Ther 1980; 212: 382-389.
9. Duman RS, Strada SJ, Enna SJ. Effects of imipramine and adenocorticotropin administration on the rat brain norepinephrine-coupled cyclic nucleotide generating system: alterations in α and β adrenergic components. J Pharmacol Exp Ther 1985; 234: 382-389.
10. 1-adrenoceptors: characterization and evidence for a functional role in the regulation of serum melatonin. Endocrinology 1985; 116: 1960-1967.
11. Etgen AM, Petitti N. Mediation of norepinephrine-stimulated cyclic AMP accumulation by adrenergic receptors in hypothalamic and preoptic area slices: Effects of estradiol. J Neurochem 1987; 49: 1732-1739.
12. 1 adrenoceptor augmentation of β-stimulated cAMP formation is enhanced by estrogen and reduced by progesterone in rat hypothalamic slices. J Neurosci 1990; 10: 2842-2849.
13. 1 and β-adrenoceptor intercommunication in rat hypothalamic slices. J Neurochem 1991; 56: 628-635.
14. 2 noradrenergic receptors in hypothalamus of female rats. Neurochem Intl 1990; 16: 1-9.
15. 1B-noradrenergic receptors in the hypothalamus and preoptic area. J Neurosci 1992; 12: 3869-3876.
16. Bylund DB, Eikenberg DC, Hieble JP, et al IV. International Union of Pharmacology Nomenclature of Adrenoceptors. Pharmacol Rev 1994; 46: 121-136.
17. Gronemeyer H. Transcription activation by estrogen and progesterone receptors. Ann Rev Genet 1991; 25: 89-123.
18. 1b adrenergic receptor. Gene 1993; 131: 243-247.
19. McCune SK, Voigt MM. Regional brain distribution and tissue ontogenic expression of a family of α-adrenergic receptor mRNAs in the rat. J Mol Neurosci 1991; 3: 29-37.
20. 1-adrenergic receptor subtype classification. Mol Pharmocol 1994; 46: 221-226.
21. Fernandez-Guasti A, Larsson K, Beyer C. Prevention of progesterone-induced lordosis behavior by alpha or beta adrenergic antagonists in ovariectomized estrogen-primed rats. Pharmacol Biochem Behav 1985; 22: 279-282.
22. Thornton JE, Goy RW, McEwen BS, Feder HH. Alpha 1 noradrenergic antagonism decreases hormonally induced and hormonally independent lordosis. Pharmacol Biochem Behav 1989; 32: 421-424.
23. Etgen AM. Intrahypothalamic implants of noradrenergic antagonists disrupt lordosis behavior in female rats. Physiol Behav 1990; 48: 31-36.
24. Shackelford DP, Jr, McConnaughey MM, Iams SG. The effects of estradiol and mestranol on α-adrenoceptors in select regions of the rat brain. Brain Res Bull 1988; 21: 329-333.
25. Sakaue M, Hoffman BB. Glucocorticoids induce transcription and expression of the α1B adrenergic receptor gene in DDT1 MF-2 smooth muscle cells. J Clin Invest 1991; 88: 385-389.
26. Phillippe M, Saunders T, Bangalore S. A mechanism for testosterone modulation of alpha-1 adrenergic receptor expression in the DDT1 MF-2 smooth muscle myocyte. Mol Cell Biochem 1991; 100: 79-90.
27. 1b adrenergic receptor gene in liver is controlled by three promoters. J Biol Chem 1994; 269: 15762-15767.
28. 1-adrenoceptor classification. Eur J Pharmacol 1994; 268: 141-149.
29. 1 adrenoceptors in rat brain revealed by in situ hybridization experiments utilizing subtype-specific probes. J Neurosci 1994; 14: 4252-4268.
30. Roesler WJ, Vandenbark GR, Hanson RW. Cyclic AMP and the induction of eukaryotic gene transcription. J Biol Chem 1988; 263: 9063-9066.
31. Quinn PG. Distinct activation domains within cAMP response element-binding protein (CREB) mediate basal and cAMP-stimulated transcription. J Biol Chem 1993; 268: 16999-17009.
32. 1b adrenergic receptor gene middle promoter contains multiple binding sites for sequence-specific proteins including a novel ubiquitous transcription factor. J Biol Chem 1995; 270: 5614-5619.
33. Gevorkian ES. Change in the activity of various protein kinases in rat brain synaptosome fractions during the in vitro effect of estradiol. Voprosy Meditsinskoi Khimii 1991; 37: 53-54.
34. Angel P, Imagawa M, Chiu R, et al. Phorbol ester-inducible genes contain a common cis element recognized by a TPA-mediated transacting factor. Cell 1987; 49: 729-739.
35. Karin M. The AP-1 complex and its role in transcriptional control by protein kinase C. In: Cohen P, Foulkes G eds. Molecular Aspects of Cellular Regulation Amsterdam: Elsevier/North-Holland Biomedical Press. 1990; 143-161.
36. Hunter T, Karin M. The regulation of transcription by phosphorylation. Cell 1992; 70: 375-387.
37. Karin M. Signal transduction from the cell surface to the nucleus through the phosphorylation of transcription factors. Curr Opin Cell Bio 1994; 6: 415-424.
38. Nielsen DA, Shapiro DJ. Insights into hormonal control of messenger RNA stability. Mol Endocrinol 1990; 4: 953-957.
39. Levine BJ, Chodchoy N, Marzluff WF, Skoultchi AI. Coupling of replication type histone mRNA levels to DNA synthesis requires the stem-loop sequence at the 3′ end of the mRNA. Proc Natl Acad Sci 1987; 84: 6189-6193.
40. Huez G, Bruck C, Cleuter Y. Translational stability of native and deadenylylated rabbit globin mRNA injected into HeLa cells. Proc Natl Acad Sci 1981; 78: 908-911.
41. Kanasaki M, Maatsubara H, Murasawa S, Masaki H, Nio Y, Inada M. cAMP responsive element-mediated regulation of the genetranscription of the α1B adrenergic receptor by thyrotropin. J Clin Invest 1994; 94: 2245-2254.
42. 1B-adrenergic receptor gene expression in rat liver cell lines. Biochim Biophys Acta 1994; 1219: 669-676.
43. 1A-adrenergic receptor. J Biol Chem 1991; 266: 6365-6369.
44. Tokunaga K, Taniguchi H, Yoda K, Shimizu M, Sakiyama S. Nucleotide sequence of a full-length cDNA for mouse cytoskeletal β-actin mRNA. Nuc Acids Res 1986; 14: 2829.